RankAlpha logo
Back to Rankings

XBIO

Xenetic BiosciencesD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Xenetic has positive translational DNase data, a newly approved exploratory CAR-T combination study, and recurring royalty revenue that may extend development capacity. [#SEC-8K-2026-08-07]
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
Cash declined from approximately $7.9 million at December 31, 2025 to $6.5 million at June 30, 2026.
Momentum
63
Value
41
Sentiment
45
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $3.30 · Bull $5.00 · Bear $2.00Analysis 2026-08-13; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-11 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-13 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-09-11

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-11. Definitions

Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Why
Momentum63 · Δ7d -
Value41 · Δ7d -0.0
Sentiment45 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.

Confirming evidence

  • Sentiment remains the lead driver in the composite.

Contradictions & invalidation

  • Cash declined from approximately $7.9 million at December 31, 2025 to $6.5 million at June 30, 2026.
  • No verified analyst estimate revisions, target changes, or post-print market-reaction attribution are available.
  • The company remains loss-making, cash declined to approximately $6.5 million by June 30, 2026, and G&A increased materially during the strategic review.

Catalyst clock

2026-11-11

Q2 2026 results provide mixed read-through

Lead driver: Sentiment · See AI snapshot
Momentum
63
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
45
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade D. Momentum 62.9 / Value 41.2 / Sentiment 45.1

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-13. Scenario method

B+
Bull case
20%
Probability
Target price
$5.00
Analysis reference price unavailable
Analysis 2026-08-13 · RankAlpha Sentiment Codex
Most likely
B
Base case
55%
Probability
Target price
$3.30
Analysis reference price unavailable
Analysis 2026-08-13 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$2.00
Analysis reference price unavailable
Analysis 2026-08-13 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$7.64M
Beta
2.30
Shares Out
2.34M
P/E (TTM) · Derived
-2.1
P/S (TTM)
1.76
P/FCF (TTM) · Derived
-2.84
Rev YoY
+12.0%
EPS YoY
-9.3%
Gross Margin
+94.4%
Op Margin
-81.0%
Net Debt
-$7.88M
Current Ratio
7.43
As of 2026-09-11 • Updated nightlySource: Internal modelMethods & Data